Sign in

CIK 0001853816 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Dermata Therapeutics, Inc.

Sign in to watch
Ticker
DRMA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(858)-223-0882
Business address
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO, CA, 92130
Former names
Dermata Therapeutics, Inc.
  1. CORRESP Other Correspondence Between Filers and SEC Staff
  2. S-3/A Offering Registration Statement
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. ARS Other Annual Report to Security Holders
  8. DEFA14A Proxy Proxy Materials
  9. DEF 14A Proxy Proxy Statement
  10. PRE 14A Proxy Proxy Statement (Preliminary)
  11. 10-K Report Annual Report
  12. 8-K Event Results of operations
  13. 4 Open-market buy SVP, Regulatory Affairs bought 1,000 shares at $1.27 ($1,270)
  14. 8-K Event Executive or director change
  15. SCHEDULE 13D/A Stake Beneficial Ownership Report
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  19. 8-K Event Auditor change
  20. SCHEDULE 13D/A Stake Beneficial Ownership Report

Page 2 of 19 · 373 filings